Form D — Los Angeles Biosciences, Inc.
0002074477-25-000002 · filed Jun 24, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $4,869,444
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Los Angeles Biosciences, Inc.
- CIK
- 2074477
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 419 WATERVIEW STREET
PLAYA DEL REY, California 90293 - Phone
- 907.350.7848
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Derya L. Kelter · Executive OfficerPlaya Del Rey, California Find on LinkedIn ↗
-
Ketan Patel · DirectorCalabasas, California Find on LinkedIn ↗
-
Jeff Nichols · Executive OfficerAtlanta, Georgia Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗